Actively Recruiting

Phase 2
Age: 50Years - 90Years
All Genders
NCT05700825

Rehabilitation of Airway Protection in Parkinson's Disease

Led by Teachers College, Columbia University · Updated on 2025-09-24

120

Participants Needed

2

Research Sites

263 weeks

Total Duration

On this page

Sponsors

T

Teachers College, Columbia University

Lead Sponsor

N

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Airway protective disorders are a prevalent and progressive consequence of Parkinson's Disease (PD), and often result in aspiration pneumonia which is the leading cause of death in PD. Despite this, a large number of patients with PD do not access specialized services to address these critical deficits. The investigators will examine the comparative effectiveness of a novel treatment paradigm delivered in-person versus via telehealth in persons with PD, as well as the role of patient burden and treatment adherence on outcomes; thus, the proposed research is relevant to public health and in line with NIH's mission to identify novel, efficacious, and accessible rehabilitation strategies for short- and long-term improvement of dysfunctional airway protection in PD.

CONDITIONS

Official Title

Rehabilitation of Airway Protection in Parkinson's Disease

Who Can Participate

Age: 50Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with Parkinson's Disease at Hoehn and Yahr Stages II-IV confirmed by a Movement Disorders specialist using strict UK brain bank criteria
  • Presence of airway protective deficits shown by penetration of thin liquids or reduced cough strength
  • Not currently receiving exercise-based swallowing therapy
  • Aged between 50 and 90 years
Not Eligible

You will not qualify if you...

  • Other neurological disorders such as multiple sclerosis, stroke, or brain tumor
  • History of head and neck cancer
  • History of breathing disorders like COPD
  • Smoking history in the last five years
  • Uncontrolled hypertension
  • Severe neuropsychological dysfunction including severe depression or dementia
  • Allergy to capsaicin or barium
  • Living more than 1.5 hours away from either Teachers College, Columbia University or Purdue University

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Purdue University

West Lafayette, Indiana, United States, 47907

Actively Recruiting

2

Teachers College, Columbia University

New York, New York, United States, 10027

Active, Not Recruiting

Loading map...

Research Team

M

Michelle Troche, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here